NXN-462

· NeurAxon Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NXN-462, covering 2014-06-19 to 2014-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia [Phase 2]